Brickroad
Brickroad
IndexSignalsBlog
/Index//

Product

  • Information Frontier Agent
  • Vendor Management Agent
  • Product Tour
  • Pricing

Solutions

  • All Solutions
  • Atlas
  • Wayfinder
  • Horizon

Suppliers

  • Sell Your Data
  • Start Onboarding
  • Programmatic Data License

Community

  • Public Index
  • Signals
  • Blog

Company

  • About
  • Team
  • Careers
  • Brand

Connect

  • LinkedIn
  • X
PrivacyTermsCookies

© 2026 Brickroad

/Index/Inovalon/Inovalon
I

Inovalon

INOVALONManage supplier listing

A very large longitudinal US medical- and pharmacy-claims real-world data network (fed through payer, provider and pharmacy workflow products) surfaced for trial use as a per-criterion eligibility determination: for each patient, the structured history of diagnoses, labs, prescriptions, procedures and vaccinations is evaluated against a protocol's inclusion and exclusion criteria and returns pass / fail / inconclusive per criterion, in de-identified form and in near-real time. Also licensed separately as de-identified EHR data for screening, giving claims-plus-chart breadth.

Open buyer room →
Inovalon/Inovalon
SampleCoverage

Sample

Brickroad customers

Sample this dataset before you buy it.

Your sourcing agent asks Inovalon and files the sample in your catalog — private to you.

Start 7-day trial→Nothing is charged until the trial ends.

Coverage

Universe, instruments and categories.

Industry
Health Care TechnologyLife Sciences Tools & Services
Instruments
equities
Categories
AlternativeFundamentalReference
Regions
US
Sample tickers
IQVCVSCIELVABCMSIGPFELLY
Dataset card
Type
not stated
Format
Tabular — coded claims and EHR records (diagnosis, lab, prescription, procedure, immunisation) delivered as per-criterion pass/fail/inconclusive determinations through API integration
Volume
Not stated on this page. Order-of-magnitude estimate: a national medical-plus-prescription claims network of this enterprise scale implies 10^10+ claim lines and comparable pharmacy dispense events annually, each longitudinally linked per patient; the eligibility product adds one pass/fail/inconclusive evaluation per patient per protocol criterion per screening run, so at production referral volumes this alone reaches 10^7-10^8 determinations a year. Request the licensable-network size and current vintage.
Users
N/A as registered users — a population-data asset, not an account product. The relevant denominator is the covered population behind the payer, provider and pharmacy networks, which at this enterprise scale (~4,900 employees, revenue range $749.6M) implies tens of millions of lives. Exact covered-life count is not printed on the product page — confirm with the data team.
History
20 years
Update frequency
not stated
Growth
Active — current conference-circuit investment (an October 2026 AMCP Nexus banner with a booked-meeting funnel) built around an explicit strategy of extending from claims into chart/EHR data, alongside a broad and actively marketed four-cloud product estate. This is a mature, well-capitalised enterprise expanding the data estate rather than a startup seeking scale.
Launched
Underlying claims data business dates to roughly 2014 or earlier by firmographic signals and the site's own 2021 logo assets, i.e. the data network is well over a decade old. The Clinical Trial Eligibility Screener as a named product is far newer — part of the recent claims-into-chart expansion — plausibly 2023-2025.
Delivery
not stated
Entity mapping
not stated
Sample
not stated
Point-in-time
not stated
Licence
not stated

supplier index read from their site

Inovalon has not added their own details yet. Not yet on file:

  • Dataset
  • Data dictionary
  • Coverage
  • Provenance
  • Rights & data handling